Avid Radiopharmaceuticals

Avid's Amyvid Recommended for Approval In Europe as Diagnostic Tool for Alzheimer's Disease Read more here

FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Read more here

Lilly Snags Avid in $800M Buyout Deal Read more here

Expert: Avid Could Launch Alzheimer's Agent Ahead of GE, Bayer Read more here

Promise Seen for Detecting Alzheimer's (Avid Radiopharmaceuticals) Read more here

PETNET Avid Announcement Read more here